Presenter: Kevin Spelman, PhD

Original Date: July 29, 2017

Besides THC there are at least 60 other cannabinoids in the Cannabis plant. Besides the fascination with THC, there is a significant amount of attention being put on cannabidiol (CBD). Importantly, this cannabinoid does not induce euphoria but does show some intriguing activity in a number of molecular pathways, tissues and physiological systems. Beyond attenuating the euphoria of THC, anxiolytic, anti-inflammatory, analgesic, anti-seizure, anti-addictive and anti-neoplastic activities are prominent. In addition, it puts other receptors into play besides the CBRs. This presentation examines the evidence base for CBD, which is growing rapidly and offers broad spectrum and significant therapeutic potential.

1.5 Pharmacology CEUs approved by OBNM